Skip to main content
. 2022 Jul 31;51:404–411. doi: 10.1016/j.clnesp.2022.07.011

Table 2.

Comparison of patients' characteristics (paraclinical data) according to COVID-19-related severity.

Patient Characteristics Mean ± Std dev Disease Severity
p-value
Mild (n = 26) Moderate (n = 30) Severe (n = 37)
Blood Test Resultsa Zinc (μg/dL) 67.61 ± 15.10 69.1 ± 15.2 69.4 ± 17.8 65.0 ± 12.4 0.417
Calcium (mg/dL) 9.14 ± 0.39 9.2 ± 0.3 9.1 ± 0.4 9.0 ± 0.3 0.043∗
Vitamin D (ng/mL) 11.21 ± 21.40 20.0 ± 10.4 19.1 ± 11.2 24.5 ± 11.4 0.077
FBS (mg/dL) 151.56 ± 80.78 105.5 ± 36.4 140.9 ± 78.5 173.1 ± 86.6 0.028∗
BUN (mg/dL) 17.97 ± 12.89 13.3 ± 3.6 21.0 ± 18.5 18.4 ± 11.0 0.301
Cr (mg/dL) 1.08 ± 0.48 0.9 ± 0.1 1.1 ± 0.6 1.1 ± 0.4 0.169
NA (mmol/L) 138.29 ± 12.43 140.4 ± 1.8 139.3 ± 4.4 136.3 ± 18.2 0.344
K (mmol/L) 4.92 ± 4.77 6.6 ± 9.6 4.2 ± 0.3 4.4 ± 0.5 0.236
WBC (109/L) 6.81 ± 2.63 6.9 ± 2.3 6.4 ± 3.3 6.9 ± 2.3 0.814
RBC (1012/L) 4.53 ± 0.64 4.6 ± 0.4 4.3 ± 0.5 4.5 ± 0.7 0.329
Hb (g/dL) 12.46 ± 1.55 13.1 ± 1.4 12.4 ± 1.6 12.1 ± 1.5 0.06
HCT (%) 37.96 ± 4.16 39.0 ± 4.6 36.8 ± 4.3 38.1 ± 3.7 0.280
PLT (109/L) 224.96 ± 84.71 232.2 ± 61.7 193.6 ± 71.0 240.1 ± 98.4 0.140
Lym (109/L) 27.65 ± 18.19 27.4 ± 16.5 29.2 ± 16.6 26.7 ± 20.2 0.520
Neut (109/L) 67.24 ± 12.53 68.0 ± 12.2 62.9 ± 15.2 69.5 ± 10.2 0.174
PH 7.37 ± 0.06 7.3 ± 0.04 7.3 ± 0.04 7.3 ± 0.08 0.869
pCO2 (mmHg) 37.54 ± 6.68 38.2 ± 4.5 37.2 ± 7.0 37.2 ± 8.0 0.947
pO2 (mmHg) 34.56 ± 11.83 35.0 ± 12.0 34.4 ± 12.6 34.5 ± 11.1 0.101
HCO3 (meq/L) 22.03 ± 2.35 21.5 ± 0.6 21.6 ± 2.5 22.6 ± 2.9 0.554
ESR (mm/hr) 37.42 ± 24.87 33.8 ± 17.7 22.2 ± 12.1 47.0 ± 29.2 0.097

significance level: p < 0.05.

a

FBS: Fasting Blood Sugar, BUN: Blood Urea Nitrogen, Cr: Creatinine, Na: Sodium, K: Potassium, WBC: White Blood Cells, RBC: Red Blood Cells, Hb: Hemoglobin, HCT: Hematocrit, PLT: Platelet, Lym: Lymphocyte, Neut: Neutrophils, PH, pO2, pCO2, and HCO3: Arterial Blood Gas Test, ESR: Erythrocyte Sedimentation Rate.